ACTO
acto.com
Actively hiring
Health & Medical Electronics
Biologics & Biosimilars
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$29.5M
2 rounds on record
Latest round
$18M
Venture round · Jul 2022 · 4 yr ago
Backers
2
Panache Ventures, Salesforce Ventures
The money's age
Long since its last round
50 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 14
Recognition ACTO Named Among Everest Group's Top 50 Pharmaceutical Technology Providers for 2026 · acto.com
Apr 13
Launched ACTO Unveils First Ever Role-based AI SuperAgents Purpose-Built to Orchestrate Work for Life Sciences Field Teams · PRNewswire
May 8, 2025
New executive ACTO APPOINTS FORMER J&J PRESIDENT TO ITS BOARD OF DIRECTORS · PRNewswire
May 7, 2024
Launched ACTO LAUNCHES TALKTRX TO IMPROVE PHARMA FIELD REP CONVERSATIONS WITH HCPs · PRNewswire
Jul 7, 2022
Raised a round Venture round $18M · YahooFinance
Aug 27, 2020
Raised a round Venture round $11.5M · Venturebeat
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2022 | $18M | — | YahooFinance |
| Venture round | Aug 2020 | $11.5M | — | Venturebeat |
Backed byfrom the funds' portfolios and accelerator catalogs
Panache Ventures 
Salesforce Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Qufora is a medical device company that works to enable people with chronic bowel disorders to live a better life. Your life Our…
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
About Mission Leadership Life & Culture Businesses Product Integrity Cincinnati Test Systems, Inc.
Medical Device Developmentto Enhance the Quality of Life. 再生医療機器開発.
A new path forpatients with Chronic Kidney Disease. At Pathalys Pharma, Inc. we are committed to improving the lives of patients through…
Puna Bio develops crop biologicals from extremophile microorganisms. Its strains come from high-altitude Argentine environments with harsh…
News
AI Roleplay for MSLs: Preparing Medical Affairs Teams for Scientific Exchange
Medical Science Liaisons (MSLs) Need a New Model for Scientific Exchange Readiness Medical Science Liaisons play a critical role in Life Sciences field engagement. As therapies become more complex and HCP expectations rise, MSLs are often expected to serv
Read more
Report
How AI Roleplay Helps Pharma Reps Build Clinical Fluency
Clinical fluency for pharma reps is the new standard for pharma field teams. Pharmaceutical sales representatives are expected to do more than deliver a message. They need to communicate complex science clearly, confidently, and compliantly in conversatio
Read more
Report
ACTO Named Among Everest Group's Top 50 Pharmaceutical Technology Providers for 2026
Recognition underscores ACTO's leadership in AI-powered field excellence and agentic AI purpose-built for Life Sciences TORONTO and NEW YORK-September 14, 2026 - ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced its inc
Read more
Report
ACTO Achieves Veeva Gold Product Partner Status, Following a Nearly Decade-Long Collaboration Supporting Mutual Customer Success
ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced it has achieved Veeva Gold Product Partner status, building on a longstanding collaboration focused on improving field team effectiveness, compliance, and customer engag
Read more
Report
ACTO Achieves Veeva Gold Product Partner Status, Following a Nearly Decade-Long Collaboration Supporting Mutual Customer Success
Validated integrations with Veeva applications help Life Sciences field teams train, practice, and execute with approved content and real-time intelligence TORONTO and NEW YORK-September 2, 2026 - ACTO, uniting human intelligence with empathetic AI in Lif
Read more
Report
What Is AI Roleplay for Life Sciences Sales Enablement?
AI Roleplay Is Redefining Life Sciences Sales Enablement Life Sciences sales enablement has always had one central goal: prepare field teams to have better conversations with healthcare professionals. But the standard for those conversations has changed.
Read more
Report
Why Traditional Pharma Sales Training Is Failing Field Teams
Traditional Pharma Sales Training Has a Performance Problem Life Sciences companies invest significant time, money, and resources into pharma sales training: new hire onboarding, product launch training, national sales meetings, certification programs, LM
Read more
Report
The HCP Engagement Crisis: Why Life Sciences Field Teams Need a New Approach to Readiness
The HCP Engagement Crisis Is a Field Readiness Crisis Life Sciences field teams are facing a difficult reality: healthcare professionals are harder to reach, harder to engage, and less willing to spend time in conversations that do not immediately deliver
Read more
Report
Agentic AI Is Not Another Tool. It Is a New Commercialization Model.
AI is quickly reshaping Life Sciences commercialization, creating an opportunity to use Agentic AI to reduce complexity and help people work more effectively-not simply add another tool to the commercialization model. Customer-facing professionals already
Read more
Report
ACTO: July 8th 2026, Production Release
These release notes are a consolidation of all the issues and enhancements from the July 8th, 2026 Production release. Here are the details: Mobile New Features Admin Session Timeout (Android): Automatic session timeout has been brought to Android, allowi
Read more
Report
Show more news